Blake Kimbrell, MD
Otolaryngology · Athens, GANPI 1144545096
Payments from drug & device makers
Across 75 payments — averaging $26.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$330
- Aerin Medical Inc.$280
- Regeneron Healthcare Solutions, Inc.$199
- Kaleo, Inc.$181
- Optinose US, Inc.$167
- Inspire Medical Systems, Inc.$159
- plus $654 from 13 others
What the payments were for
- Food & beverage$1,93598%
- Education$342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 8 | $330 |
| Aerin Medical Inc. | 6 | $280 |
| Regeneron Healthcare Solutions, Inc. | 7 | $199 |
| Kaleo, Inc. | 12 | $181 |
| Optinose US, Inc. | 8 | $167 |
| Inspire Medical Systems, Inc. | 8 | $159 |
| Medtronic(2 entities) | 4 | $151 |
| Stryker | 3 | $112 |
| GSK | 6 | $103 |
| Sanofi | 3 | $78 |
| Amgen | 2 | $51 |
| Polynovo North America LLC | 1 | $47 |
| KARL Storz Endoscopy-america | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Covidien LP | 1 | $17 |
| Merck | 1 | $15 |
| Alk-abello, Inc | 1 | $14 |
| Smith+Nephew | 1 | $13 |
How this compares
$1,969 in reported general payments places this provider in the 60th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 26 | $5,718 |
| Azelastine Hcl | 153 | $4,795 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 26 | $3,096 |
| QnaslBeclomethasone Dipropionate | 11 | $2,961 |
| Ipratropium Bromide | 98 | $1,946 |
| Fluticasone Propionate | 96 | $998 |
| Omeprazole | 79 | $806 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $506 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $490 |
| Mometasone Furoate | 12 | $413 |
| Ofloxacin | 13 | $388 |
| Ondansetron OdtOndansetron | 39 | $387 |
| Doxycycline Hyclate | 25 | $342 |
| Mupirocin | 18 | $139 |
| Montelukast Sodium | 16 | $99 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Athens
- John TrimbleAcworth$1.1M
- Dozier HoodFayetteville$715K
- Ramie TrittAtlanta$640K
- Howard HermanStockbridge$325K
- Christopher MelroySavannah$298K
- Karen HoffmannAtlanta$267K
- Jose StolovitzkyAtlanta$106K
- Jonathan LindmanEvans$55K
- Camilo Reyes-GelvesAugusta$41K
- Gregory PostmaAugusta$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.